Business

Ampo New's revenue in April 2025 fell by 34.52%, recording the largest decline in nearly a year.
star67
TSMC's record-breaking revenue and growth in exports are driving Taiwan's economic growth, while exchange rate fluctuations and policy adjustments are influencing future directions.

Ampo New's revenue in April 2025 fell by 34.52%, recording the largest decline in nearly a year.

2h ago

Ampo New Co., Ltd. (6743) announced on May 10, 2025, that its consolidated revenue for April was NT$406 million (New Taiwan Dollars), a decrease of 34.52% compared to NT$620 million in the same period last year, hitting a two-month low. The cumulative revenue for the first four months of 2025 reached NT$1.571 billion, a decrease of 10.92% compared to the same period last year. This represents the largest year-on-year decline over the past year, indicating that the company is experiencing revenue pressure at the start of the second quarter.

Hua Sheng-KY Co.'s revenue in April decreased by 9.19% compared to the same month last year, but the total revenue for the year has still increased by 5.73%.
star60

Hua Sheng-KY Co.'s revenue in April decreased by 9.19% compared to the same month last year, but the total revenue for the year has still increased by 5.73%.

2h ago

Hua Sheng-KY Co., Ltd. (stock code: 2248) announced on May 10th, 2025, that its consolidated revenue for April was NT$1.46 billion, a 9.19% decrease from the same period last year. However, the company's cumulative revenue for the first four months of this year reached NT$6.02 billion, a 5.73% increase from the same period last year. This shows that despite fluctuations in monthly revenue, Hua Sheng-KY Co., Ltd. has maintained steady overall revenue growth.

In April, Giga Biotech's revenue reached 105 million NTD, indicating steady growth with a 4.39% increase compared to the same period last year.
star60

In April, Giga Biotech's revenue reached 105 million NTD, indicating steady growth with a 4.39% increase compared to the same period last year.

2h ago

Biotechnology and pharmaceutical company TWi Biotech (3176) announced its April revenue report on May 10, 2025. The revenue for the month reached NT$105.2 million (New Taiwan Dollars), a 4.39% increase compared to April of the previous year. The cumulative revenue for the first four months of 2025 was NT$605 million, representing a 71.71% increase from the same period last year. This demonstrates TWi Biotech's ongoing efforts in product sales and market expansion. Although the monthly growth was moderate, the cumulative performance was impressive, highlighting its strong operational momentum.

For the first time in 28 months, TSMC Chairman C.C. Wei increased his shareholding by purchasing 20 lots of shares at the low point in April.
star43

For the first time in 28 months, TSMC Chairman C.C. Wei increased his shareholding by purchasing 20 lots of shares at the low point in April.

2h ago

In April 2025, TSMC Chairman C.C. Wei purchased 20 lots of company stock on the centralized market when the stock price plummeted due to the U.S. "reciprocal tariffs" policy. This action was his first increase since December 2022. The purchase price ranged from 841 to 868 NT dollars, with a total expenditure of approximately 16.82 million to 17.2 million NT dollars. Several other TSMC executives also increased their holdings at this time, indicating internal confidence in the stock being at a low point. This move took place after TSMC's stock price dropped below 800 NT dollars, prompting both retail and institutional investors to enter the market.

Mingxi Corporation's April revenue dropped by over 50% compared to the same month last year, primarily because of weak demand for customer orders.
star68

Mingxi Corporation's April revenue dropped by over 50% compared to the same month last year, primarily because of weak demand for customer orders.

14h ago

Mingxi Corporation (Stock Code: 6804) announced on May 9, 2025, that its consolidated revenue for April was NTD 88.266 million, a decrease of 50.26% compared to NTD 177.466 million in the same period last year. The cumulative revenue for the first four months of this year was NTD 429.635 million, a decrease of 30.81% compared to the same period last year. The company stated that the decline in revenue was mainly due to a decrease in customer orders, highlighting the impact of weak market demand on the company's performance.

Yulon Motor's April revenue dropped by 27%, bringing the total revenue decline to 17% for the first four months.
star58

Yulon Motor's April revenue dropped by 27%, bringing the total revenue decline to 17% for the first four months.

14h ago

Yulon Motor announced its revenue data for April 2024 on May 9, 2025. The consolidated revenue for the month was NT$56.04 billion, a decrease of 27.41% compared to NT$77.20 billion in the same period last year. Cumulatively, by the end of April, Yulon's consolidated revenue for the first four months of this year was NT$234.75 billion, a decrease of 17.24% compared to the same period last year. The decline in revenue reflects challenges including reduced sales of brand models, adjustments in subsidiary operations, and weak market demand.

In April 2025, Sheng Yue-KY Co.'s revenue decreased by 31.89%, with a cumulative revenue decrease of 24.09%.
star50

In April 2025, Sheng Yue-KY Co.'s revenue decreased by 31.89%, with a cumulative revenue decrease of 24.09%.

14h ago

Sheng Yue-KY Co., Ltd. (1340) announced on May 10, 2025, that its consolidated revenue for April 2025 was NT$28.106 million (New Taiwan Dollars), a 31.89% decrease from NT$41.263 million in April of the previous year. By the end of April, the total revenue amounted to NT$89.159 million, a 24.09% drop from NT$117.461 million during the same period last year. This suggests that Sheng Yue-KY is encountering persistent operational challenges, experiencing a more significant revenue decline than its industry peers.

Yulon Motor and Mitsubishi are collaborating to develop electric vehicles and plan to expand into the Australian and New Zealand markets by 2026.
star50

Yulon Motor and Mitsubishi are collaborating to develop electric vehicles and plan to expand into the Australian and New Zealand markets by 2026.

14h ago

Yulon Motor, facing a weak domestic car market and declining revenue, is implementing a diversification strategy that encompasses areas like smart manufacturing. Recently, Yulon partnered with Japan's Mitsubishi Motors and Foxtron Advanced Technology, a subsidiary of Foxconn, to roll out OEM electric vehicles in Australia and New Zealand by the latter half of 2026. This partnership extends Yulon's long-standing relationship with Mitsubishi and demonstrates its prowess in electric vehicle production and international contract manufacturing, bringing fresh momentum to Taiwan's automotive industry.

Lianxiang Co. saw a remarkable 48.79% increase in revenue this April compared to the same month last year, thanks to a significant rise in customer demand.
star72

Lianxiang Co. saw a remarkable 48.79% increase in revenue this April compared to the same month last year, thanks to a significant rise in customer demand.

16h ago

Lianxiang Co., Ltd. (3678), an over-the-counter company, announced on May 9th, 2025, that its consolidated revenue for April reached 38.067 million TWD, a 48.79% increase compared to the same period last year. The cumulative revenue for the first four months reached 159.684 million TWD, an annual increase of 79.56%. The company stated that the revenue growth was mainly due to increased customer demand, which boosted overall performance.

Tai Lung Corporation's revenue in April, 2025 reached 1.5 billion NTD, representing an annual growth of nearly 20%.
star61

Tai Lung Corporation's revenue in April, 2025 reached 1.5 billion NTD, representing an annual growth of nearly 20%.

16h ago

On May 9, 2025, Tai Long Corporation (stock code: 6246) announced its consolidated revenue for April 2025 was NT$150.138 billion, a 19.95% increase from the same period last year. The cumulative revenue for the first four months of this year reached NT$509.069 billion, a year-over-year increase of 25.10%. Despite the revenue growth, the first-quarter financial report indicated the company still faces challenges in achieving operational profitability, reporting a pre-tax net loss of NT$8.683 million and a basic loss per share amounting to NT$0.39. The company's asset structure is predominantly debt-based, requiring continuous monitoring for stability.

Tongtai Machine & Tool Co. Q1 2025 Financial Report: Consolidated profit of NT$34.46 million for Q1 2025, EPS NT$0.14 per share, as approved by the board of directors.
star43

Tongtai Machine & Tool Co. Q1 2025 Financial Report: Consolidated profit of NT$34.46 million for Q1 2025, EPS NT$0.14 per share, as approved by the board of directors.

16h ago

Tongtai Machine & Tool Co., Ltd. (4526) held a board meeting on May 9, 2025, where they approved the consolidated financial report for the first quarter of 2025. The consolidated revenue for the quarter reached NT$1.52 billion, marking a 15% increase from the previous year. The net profit attributable to the parent company's owners was NT$34.46 million, with earnings per share of NT$0.14, marking a successful return to profitability. Despite an operating loss, Tongtai achieved a net profit after tax through non-operating income, indicating financial stability. The board also approved strategic investments to strengthen market competitiveness.

In April 2025, Guangyun's revenue saw a year-on-year decrease of 25.22%, with overall revenue continuing to fall.
star68

In April 2025, Guangyun's revenue saw a year-on-year decrease of 25.22%, with overall revenue continuing to fall.

22h ago

Guangyun Co., Ltd. (6125) announced on May 9, 2025, that its consolidated revenue for April was NT$2.18 billion, a decrease of NT$734.16 million compared to the same period last year, representing a year-on-year decline of 25.22%. The cumulative revenue for the first four months was NT$8.31 billion, down 7.72% compared to the same period last year. The revenue decline suggests the company is under operational pressure. No specific reasons were provided, but it may be affected by global supply chain fluctuations and industry market conditions.

Pian An Technology's revenue in April, 2025 reached 95,100,000 NTD, an annual increase of 21.71%.
star67

Pian An Technology's revenue in April, 2025 reached 95,100,000 NTD, an annual increase of 21.71%.

22h ago

Pian An Technology Co., Ltd. (8088) announced on May 9, 2025, that its consolidated revenue for April was NT$95.105 million, a 21.71% increase compared to the same period last year. The total revenue for the first four months of this year reached NT$386.827 million, a year-over-year increase of 11.16%. Despite fluctuations in monthly revenue, Pian An has maintained steady growth in the face of the volatile demand and fierce competition in the memory market, indicating the effectiveness of its product strategy and market positioning adjustments.

MeiShi Pharma will participate in the KGI Securities Chinese Online Institutional Investor Conference on May 21.
star60

MeiShi Pharma will participate in the KGI Securities Chinese Online Institutional Investor Conference on May 21.

22h ago

MeiShi Pharmaceutical Corporation (Stock Code: 1795) announced on May 9, 2025, that it will participate in the Chinese-language online corporate investor conference hosted by KGI Securities at 2 PM on May 21. This event aims to facilitate communication between corporate investors and the company and has been announced on the Public Information Observation Post as constituting a significant information disclosure.

MediaTek's revenue in April was NT$487.54 billion, an annual increase of 16%. It is estimated that second-quarter revenue will remain stable with a gross margin of 47%.
star60

MediaTek's revenue in April was NT$487.54 billion, an annual increase of 16%. It is estimated that second-quarter revenue will remain stable with a gross margin of 47%.

22h ago

MediaTek announced on May 9, 2025, that its April revenue was NT$48.754 billion, a decrease of 12.93% compared to March, but an increase of 16% compared to the same period last year, marking the second highest for the same period in history. The cumulative revenue for the first four months was NT$202.067 billion, an annual increase of 15.15%. The estimated revenue for the second quarter is between NT$147.2 and NT$159.4 billion, remaining stable compared to the first quarter, with an annual increase of 16% to 25%. The gross margin is estimated to be 47%, with a variance of plus or minus 1.5%, and the expense ratio is estimated at 29%, with a variance of plus or minus 2%. The company emphasized the growth momentum of smart devices and PMIC, and highlighted its AI collaboration strategies at the supplier conference.